Intrexon Corp., 10% Owner at Synthetic Biologics, Inc. (SYN), bought 2,500,000 shares at $1.00 ($2.5M) on 2013-12-17, disclosed to the SEC on 2013-12-19.
Open-market purchase of $2.5M SYN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.00 | 500,000 | $500K | 20.0% |
| 2 | $1.00 | 2,000,000 | $2.0M | 80.0% |
| Total | $1.00 avg | 2,500,000 | $2.5M | 100% |
| Filing → |
| AQB | BUY | 2018-01-19 | $10.0M | — | Filing → |
| FCSC | BUY | 2017-12-13 | $4.2M | — | Filing → |
| AQB | BUY | 2017-01-20 | $25.0M | — | Filing → |